(Q50969746)

26 March 2018

title

Immunogenicity of two versus three injections of inactivated hepatitis A vaccine in adults. (English)

1 reference

26 March 2018

1 reference

1 reference

X Q Chen

1

1 reference

26 March 2018

M Bülbül

2

1 reference

26 March 2018

G C de Gast

3

1 reference

26 March 2018

A M van Loon

4

1 reference

26 March 2018

D R Nalin

5

1 reference

26 March 2018

J van Hattum

6

1 reference

26 March 2018

publication date

1 February 1997

1 reference

26 March 2018

published in

Journal of Hepatology

1 reference

26 March 2018

volume

26

1 reference

26 March 2018

issue

2

1 reference

26 March 2018

page(s)

260-264

1 reference

26 March 2018

Prevention of endemic icteric viral hepatitis by administration of immune serum gamma globulin

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980039-6

7 January 2021

Transmission of Hepatitis A by Transfusion of Blood Products

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980039-6

7 January 2021

A controlled trial of a formalin-inactivated hepatitis A vaccine in healthy children

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980039-6

7 January 2021

Inactivated hepatitis A vaccine in childhood: implications for disease control

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980039-6

7 January 2021

Safety, tolerability, and immunogenicity of an inactivated hepatitis A vaccine: effects of single and booster injections, and comparison to administration of immune globulin

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980039-6

7 January 2021

Clinical trial with inactivated hepatitis A vaccine and recommendations for its use

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980039-6

7 January 2021

Safety profile and immunogenicity of an inactivated vaccine derived from an attenuated strain of hepatitis A.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980039-6

7 January 2021

New findings in live, attenuated hepatitis A vaccine development

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980039-6

7 January 2021

Development of the formalin-inactivated hepatitis A vaccine, VAQTA from the live attenuated virus strain CR326F.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980039-6

7 January 2021

Clinical assessment of the safety and efficacy of an inactivated hepatitis A vaccine: rationale and summary of findings

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980039-6

7 January 2021

Immune response to hepatitis B revaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980039-6

7 January 2021

Simultaneous active and passive immunization against hepatitis A studied in a population of travellers

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980039-6

7 January 2021

Efficacy of heat-inactivated hepatitis B vaccine in haemodialysis patients and staff. Double-blind placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980039-6

7 January 2021

Intradermal hepatitis B immunization with yeast-derived vaccine: serological response by sex and age.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980039-6

7 January 2021

Alterations in the human immune response to the hepatitis B vaccine among the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980039-6

7 January 2021

Dose response study of an inactivated hepatitis A virus vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980039-6

7 January 2021

Safety and Immunogenicity of a Live Attenuated Hepatitis A Virus Vaccine in Seronegative Volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980039-6

7 January 2021

Primary study of attenuated live hepatitis A vaccine (H2 strain) in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980039-6

7 January 2021

An inactivated hepatitis A viral vaccine of cell culture origin

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980039-6

7 January 2021

10.1016/S0168-8278(97)80039-6

Identifiers

DOI

1 reference

26 March 2018

1 reference

26 March 2018